- Home
- PTLO vs LENZ Comparison
PTLO vs LENZ Comparison
Compare PTLO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- LENZ
- Stock Information
- Founded
- PTLO 1963
- LENZ 2019
- Country
- PTLO United States
- LENZ United States
- Employees
- PTLO N/A
- LENZ N/A
- Industry
- PTLO Restaurants
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- PTLO Consumer Discretionary
- LENZ Health Care
- Exchange
- PTLO Nasdaq
- LENZ Nasdaq
- Market Cap
- PTLO 821.9M
- LENZ 886.2M
- IPO Year
- PTLO 2021
- LENZ 2021
- Fundamental
- Price
- PTLO $9.23
- LENZ $32.77
- Analyst Decision
- PTLO Buy
- LENZ Strong Buy
- Analyst Count
- PTLO 7
- LENZ 6
- Target Price
- PTLO $14.00
- LENZ $35.40
- AVG Volume (30 Days)
- PTLO 1.3M
- LENZ 105.1K
- Earning Date
- PTLO 11-05-2024
- LENZ 11-06-2024
- Dividend Yield
- PTLO N/A
- LENZ N/A
- EPS Growth
- PTLO 56.82
- LENZ N/A
- EPS
- PTLO 0.42
- LENZ N/A
- Revenue
- PTLO $713,803,000.00
- LENZ N/A
- Revenue This Year
- PTLO $6.53
- LENZ N/A
- Revenue Next Year
- PTLO $11.42
- LENZ N/A
- P/E Ratio
- PTLO $21.58
- LENZ N/A
- Revenue Growth
- PTLO 11.02
- LENZ N/A
- 52 Week Low
- PTLO $8.66
- LENZ $2.23
- 52 Week High
- PTLO $16.85
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- PTLO 19.76
- LENZ 49.37
- Support Level
- PTLO $8.78
- LENZ $30.56
- Resistance Level
- PTLO $10.69
- LENZ $34.73
- Average True Range (ATR)
- PTLO 0.43
- LENZ 2.21
- MACD
- PTLO -0.14
- LENZ -0.66
- Stochastic Oscillator
- PTLO 2.78
- LENZ 32.86
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.